Casey is officially part of the study we’ve all been discussing. Unfortunately, as a condition of his participation, I’m no longer allowed to discuss it on social media.
A few things I will say include:
It was even more expensive than expected.
As I posted on Fallon’s blog, I believe the only chemo therapy a dog can (and must) receive prior to participation is Carboplatin and or Doxorubicin. Metronomic medications such as Cytoxan are not allowed. This makes sense because the study drug is trying to stimulate the immune system and Cytoxan is an immunosuppressant.
Casey is resting quietly today, but be advised there are definite side effects to this therapy. The protocol requires two hours of IV fluids in advance and then six hours of follow-up monitoring. Casey was at the vet for nine hours yesterday, and the entire oncology service at a large veterinary hospital was dedicated to Casey for the day, somewhat explaining the high cost. They were in regular communication with the study sponsor throughout the day as they monitored the side effects Casey was experiencing, and I understand those side effects were as expected.
We’re not sure we will continue for the next two doses. Casey is a healthy Golden, in good shape, but he will be twelve in August. Those of us fighting osteo took our dogs’ legs to remove the pain and extend their lives, but also to improve the quality of their lives. Trust me, Casey did not enjoy yesterday and the verdict is still out on today. I know, dogs don’t pay attention to calendars or statistics, but I have to. Amputation and chemo (Carboplatin) should buy Casey a year, maybe more. Adding a metronomic therapy might help him get two years or more, but by then, Casey will be approaching fourteen, and that’s a ripe old age for any Golden. Were Casey younger and this new therapy could help him live many more years, the investment in time, money, and side effects would make more sense, but there is a fine line between helping him live, and keeping him alive.
We will see what the future holds.